T102P (p.Thr102Pro) variant of SETX (Helicase senataxin)

T102P (p.Thr102Pro) in SETX (Helicase senataxin) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data and structural context.

T102P (p.Thr102Pro) variant details